AXGN
AxoGen Inc
Price:  
34.44 
USD
Volume:  
614,957.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AxoGen EV/EBITDA

-95.9%
Upside

As of 2026-04-05, the EV/EBITDA ratio of AxoGen Inc (AXGN) is -4,592.67. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AxoGen's latest enterprise value is 1,800.33 mil USD. AxoGen's TTM EBITDA according to its financial statements is -0.39 mil USD. Dividing these 2 quantities gives us the above AxoGen EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 12.0x - 14.3x 13.2x
Forward P/E multiples 15.4x - 26.7x 19.4x
Fair Price (0.34) - 4.45 1.41
Upside -101.0% - -87.1% -95.9%
34.44 USD
Stock Price
1.41 USD
Fair Price

AxoGen EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-04-02 -4,592.67
2026-04-01 -4,478.80
2026-03-31 -4,419.22
2026-03-30 -4,179.58
2026-03-27 -4,174.29
2026-03-26 -4,302.71
2026-03-25 -4,439.08
2026-03-24 -4,350.38
2026-03-23 -4,236.52
2026-03-20 -4,108.09
2026-03-19 -4,158.40
2026-03-18 -4,129.27
2026-03-17 -4,368.91
2026-03-16 -4,380.83
2026-03-13 -4,314.63
2026-03-12 -4,237.84
2026-03-11 -4,308.01
2026-03-10 -4,096.17
2026-03-09 -3,909.49
2026-03-06 -3,812.84
2026-03-05 -3,893.60
2026-03-04 -3,901.55
2026-03-03 -3,982.31
2026-03-02 -4,090.88
2026-02-27 -4,233.87
2026-02-26 -4,256.37
2026-02-25 -4,166.34
2026-02-24 -4,335.81
2026-02-23 -4,717.12
2026-02-20 -4,706.53
2026-02-19 -4,668.13
2026-02-18 -4,699.91
2026-02-17 -4,619.15
2026-02-13 -4,432.46
2026-02-12 -4,350.38
2026-02-11 -4,521.17
2026-02-10 -4,601.93
2026-02-09 -4,525.14
2026-02-06 -4,657.54
2026-02-05 -4,521.17
2026-02-04 -4,563.54
2026-02-03 -4,694.61
2026-02-02 -4,669.46
2026-01-30 -4,646.95
2026-01-29 -4,534.41
2026-01-28 -4,548.97
2026-01-27 -4,612.53
2026-01-26 -4,629.74
2026-01-23 -4,379.51
2026-01-22 -4,269.61